
Voglibose (0.2mg) + Glimepiride (2mg) + Metformin (500mg)
Leeford Healthcare Ltd
Glimepiride 2mgPack Size
Strip of 10 tablets
Price
Save ₹2
that's 1% off!
Active composition
+2 more active ingredients
Voglibose inhibits intestinal alpha-glucosidases, delaying carbohydrate digestion and absorption, thus lowering postprandial glucose levels.
Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Medical applications
Metviron Trio 2mg Tablet is a combination medication containing glimepiride, metformin, and voglibose, used to treat type 2 diabetes mellitus. The tablet combines the sulfonylurea glimepiride, which stimulates insulin secretion, with the biguanide metformin, which reduces glucose production in the liver and increases glucose uptake in the muscles. Voglibose, a alpha-glucosidase inhibitor, slows down the digestion of carbohydrates in the small intestine, thereby reducing the postprandial glucose excursion. The combination of these three agents in Metviron Trio 2mg Tablet provides a comprehensive approach to glucose control, helping to regulate blood sugar levels and improve patient outcomes. As a once-daily tablet, Metviron Trio 2mg Tablet offers a convenient dosing regimen for patients with type 2 diabetes, simplifying their treatment and improving adherence to their medication.
How to use Metviron Trio Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Metviron Trio 2mg Tablet is to be taken with food.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is unsafe to consume alcohol with Metviron Trio 2mg Tablet.
High Risk
Metviron Trio 2mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Metviron Trio 2mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Metviron Trio 2mg Tablet may be needed. Please consult your doctor. Metviron Trio 2mg Tablet is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
Regular Checkup
Metviron Trio 2mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Consult Doctor
Metviron Trio 2mg Tablet is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor. Use of Metviron Trio 2mg Tablet is, however, not recommended in patients with severe kidney disease.
Regular Checkup
0 reviews for Metviron Trio 2mg Tablet

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Leeford Healthcare Ltd
Glimepiride 2mgPack Size
Strip of 10 tablets
Price
Save ₹2
that's 1% off!
Active composition
+2 more active ingredients
Voglibose inhibits intestinal alpha-glucosidases, delaying carbohydrate digestion and absorption, thus lowering postprandial glucose levels.
Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Medical applications
Metviron Trio 2mg Tablet is a combination medication containing glimepiride, metformin, and voglibose, used to treat type 2 diabetes mellitus. The tablet combines the sulfonylurea glimepiride, which stimulates insulin secretion, with the biguanide metformin, which reduces glucose production in the liver and increases glucose uptake in the muscles. Voglibose, a alpha-glucosidase inhibitor, slows down the digestion of carbohydrates in the small intestine, thereby reducing the postprandial glucose excursion. The combination of these three agents in Metviron Trio 2mg Tablet provides a comprehensive approach to glucose control, helping to regulate blood sugar levels and improve patient outcomes. As a once-daily tablet, Metviron Trio 2mg Tablet offers a convenient dosing regimen for patients with type 2 diabetes, simplifying their treatment and improving adherence to their medication.
How to use Metviron Trio Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Metviron Trio 2mg Tablet is to be taken with food.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is unsafe to consume alcohol with Metviron Trio 2mg Tablet.
High Risk
Metviron Trio 2mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Metviron Trio 2mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Metviron Trio 2mg Tablet may be needed. Please consult your doctor. Metviron Trio 2mg Tablet is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
Regular Checkup
Metviron Trio 2mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Consult Doctor
Metviron Trio 2mg Tablet is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor. Use of Metviron Trio 2mg Tablet is, however, not recommended in patients with severe kidney disease.
Regular Checkup
0 reviews for Metviron Trio 2mg Tablet













